Bank of America
DERM icon

Bank of America’s Journey Medical DERM Stock Holding History

Bank of America’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$151K Buy
32,206
+21,401
+198% +$166K ﹤0.01% 5442
2025
Q4 		$83.3K Sell
10,805
-10,732
-50% -$84.1K ﹤0.01% 5679
2025
Q3 		$153K Buy
21,537
+17,403
+421% +$126K ﹤0.01% 6401
2025
Q2 		$29.7K Buy
4,134
+4,048
+4,707% +$28K ﹤0.01% 6962
2025
Q1 		$507 Buy
86
+4
+5% +$20 ﹤0.01% 7515
2024
Q4 		$321 Hold
82
– – ﹤0.01% 7495
2024
Q3 		$463 Buy
82
+11
+15% +$57 ﹤0.01% 7395
2024
Q2 		$400 Sell
71
-22,585
-100% -$92.9K ﹤0.01% 7396
2024
Q1 		$83.4K Buy
22,656
+22,484
+13,072% +$97.8K ﹤0.01% 6324
2023
Q4 		$991 Buy
+172
New +$766 ﹤0.01% 7206
2023
Q1 		– Sell
-14
Closed -$26 – 7889
2022
Q4 		$26 Buy
+14
New +$28 ﹤0.01% 7925

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of America's DERM Position: Q1 2026 in Review

Bank of America increased its Journey Medical (DERM) stake by 198% in Q1 2026, buying an estimated $166K and bringing the position to 32,206 shares worth $151K. The position accounts for ﹤0.01% of the portfolio, ranked #5442.

Bank of America first reported a position in DERM in Q4 2022 and has held it in 11 quarters since. The position peaked at $153K in Q3 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • Bank of America held 32,206 shares of Journey Medical worth $151K as of Q1 2026.
  • Bank of America bought 21,401 Journey Medical shares in Q1 2026, an estimated $166K.
  • Journey Medical made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5442 holding.
  • Bank of America first reported a position in Journey Medical in Q4 2022 and has held it in 11 quarters since.
  • Bank of America's Journey Medical position peaked at $153K in Q3 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.